SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-013721
Filing Date
2019-03-13
Accepted
2019-03-13 16:24:24
Documents
9
Period of Report
2019-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv516100_8k.htm 8-K 30915
2 EXHIBIT 4.1 tv516100_ex4-1.htm EX-4.1 103300
3 EXHIBIT 5.1 tv516100_ex5-1.htm EX-5.1 8110
4 EXHIBIT 10.1 tv516100_ex10-1.htm EX-10.1 193951
5 EXHIBIT 99.1 tv516100_ex99-1.htm EX-99.1 53220
6 EXHIBIT 99.2 tv516100_ex99-2.htm EX-99.2 10096
7 GRAPHIC tv516100_ex5-1img1.jpg GRAPHIC 14270
8 GRAPHIC tv51600_ex99-1img1.jpg GRAPHIC 10724
9 GRAPHIC tv516100_ex99-2img1.jpg GRAPHIC 18841
  Complete submission text file 0001144204-19-013721.txt   461753
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 19678503
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences